Convalescent plasma may lessen the odds of long COVID, study suggests Mary Van Beusekom
Centre for Disease Research and Policy,
COVID-19 patients may be less likely to develop severe illness and persistent symptoms if they are treated early with…
COVID-19 patients may be less likely to develop severe illness and persistent symptoms if they are treated early with…
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial…
Early outpatient administration of high-titre SARS-CoV-2 convalescent plasma reduced hospitalisations by more than 50%…
Study: Omicron much more infectious in US preschoolers than Delta A new study in JAMA Pediatrics shows the Omicron variant has…